E.M.D. is the recipient of fellowships from the Ter Meulen Fund of the Royal Netherlands Academy of Arts and Sciences and the Stichting Professor Michael van Vloten Fund, The Netherlands. G.J.E. is the recipient of the Shelly Patrick Research Fellowship of the Thomas E. Starzl Transplantation Institute. Work on xenotransplantation in the Thomas E. Starzl Transplantation Institute of the University of Pittsburgh is supported in part by NIH grants U01 AI068642, R21 A1074844, and U19 AI090959, and by Sponsored Research Agreements between the University of Pittsburgh and Revivicor, Blacksburg, VA. The baboons were provided by the Oklahoma University Health Sciences Center, Division of Animal Resources, which is supported in part by NIH P40 sponsored grant RR012317-09.
Collagenous colitis-like condition in immunosuppressed infant baboons†
Article first published online: 31 JAN 2012
Copyright © 2012 Crohn's & Colitis Foundation of America, Inc.
Inflammatory Bowel Diseases
Volume 18, Issue 7, pages 1325–1332, July 2012
How to Cite
Dons, E. M., Echeverri, G. J., Rigatti, L. H., Klein, E., Montoya, C., Wolf, R. F., Ijzermans, J. N.M., Cooper, D. K.C. and Wagner, R. (2012), Collagenous colitis-like condition in immunosuppressed infant baboons. Inflamm Bowel Dis, 18: 1325–1332. doi: 10.1002/ibd.21900
- Issue published online: 11 JUN 2012
- Article first published online: 31 JAN 2012
- Manuscript Accepted: 22 AUG 2011
- Manuscript Received: 12 AUG 2011
Collagenous colitis is a chronic inflammatory bowel disease of unknown etiology. It is fairly common in adult humans, but rare in infants, and has been associated with autoimmune disorders.
We report four infant baboons (age 7–12 months) that had received a transplant at 3 months of age and subsequent immunosuppressive therapy for periods of 4–10 months. All presented identical symptoms within a period of 4 weeks, including weight loss associated with chronic watery diarrhea that was unresponsive to standard antimicrobial treatment.
Clinical chemistry evaluations were within normal ranges, viral causes were ruled out, and fecal and blood cultures were repeatedly negative. At necropsy, two infant baboons were found to have a form of collagenous colitis. In the remaining two baboons that had identical clinical features, immunosuppressive therapy was discontinued and treatment with budesonide was initiated. Both baboons recovered and remained well on no medication until the end of follow-up (24 months).
Collagenous colitis has occasionally been reported in patients with organ transplants. It has been reported only once previously in baboons. The four cases reported here strongly suggest that 1) clinical features as well as histopathological findings of collagenous colitis in baboons are very similar to those in human patients; 2) it was associated with the immunocompromised state of the baboons, as two nonimmunosuppressed age-matched baboons in close proximity did not develop the condition; and 3) it may have had an infectious origin, as all four cases developed within a 4-week period of time. (Inflamm Bowel Dis 2012;)